DG
EVGN icon

Delek Group’s Evogene EVGN Stock Holding History

Delek Group’s Portfolio EVGN Stock Details EVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$332K Sell
21,114
-668
-3% -$12.4K 0.01% 197
2019
Q1 		$397K Buy
21,782
+871
+4% +$18.4K 0.02% 184
2018
Q4 		$425K Hold
20,911
– – 0.02% 192
2018
Q3 		$646K Hold
20,911
– – 0.03% 199
2018
Q2 		$598K Hold
20,911
– – 0.03% 207
2018
Q1 		$665K Hold
20,911
– – 0.03% 202
2017
Q4 		$641K Buy
+20,911
New +$821K 0.03% 206

Other funds holding EVGN

WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
MCM
Moon Capital Management New York $166M AUM 54.85% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
EVC
Eidelman Virant Capital Saint Louis, Missouri $136M AUM 15.11% 1-Year Est. Return

Delek Group's EVGN Position: Q2 2019 in Review

Delek Group reduced its Evogene (EVGN) stake by 3.1% in Q2 2019, selling an estimated $12.4K and leaving 21,114 shares worth $332K. The position accounts for 0.01% of the portfolio, ranked #197.

Delek Group first reported a position in EVGN in Q4 2017 and has held it in 7 quarters since. The position peaked at $665K in Q1 2018. 18 funds tracked by Wall St. Rank hold EVGN as of Q2 2019.

  • Delek Group held 21,114 shares of Evogene worth $332K as of Q2 2019.
  • Delek Group sold 668 Evogene shares in Q2 2019, an estimated $12.4K.
  • Evogene made up 0.01% of Delek Group's portfolio in Q2 2019, its #197 holding.
  • Delek Group first reported a position in Evogene in Q4 2017 and has held it in 7 quarters since.
  • Delek Group's Evogene position peaked at $665K in Q1 2018.
  • 18 funds tracked by Wall St. Rank held Evogene as of Q2 2019.

Based on Delek Group's 13F filing for Q2 2019, filed 8 Aug 2019.